Search Results - "Yousefian, Sahar"
-
1
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
Published in International immunopharmacology (01-01-2021)“…•Intravenous immunoglobulin (IVIg) administration was not effective in the management of severe COVID-19 cases.•Intravenous immunoglobulin (IVIg)…”
Get full text
Journal Article -
2
The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial
Published in Frontiers in pharmacology (19-10-2023)“…Background: Tocilizumab and baricitinib are considered standard treatments for hospitalized COVID-19 patients with an inflammatory status. However, the effects…”
Get full text
Journal Article -
3
Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial
Published in International immunopharmacology (01-11-2020)“…•The pathophysiology of SARS-CoV-2 infection may be attributed to cytokine release syndrome.•In this syndrome, interleukin 6 is released after the activation…”
Get full text
Journal Article -
4
Determination of Voriconazole Plasma Concentration by HPLC Technique and Evaluating Its Association with Clinical Outcome and Adverse Effects in Patients with Invasive Aspergillosis
Published in The Canadian journal of infectious diseases & medical microbiology (2021)“…Purpose. Invasive aspergillosis is a prevalent fungal disease, especially in Asian countries with a high mortality rate. Voriconazole (VRZ) is the first choice…”
Get full text
Journal Article -
5
Evaluating the Effects of Umifenovir Compared to Lopinavir/Ritonavir in the Management of Patients with COVID-19: A Randomized Controlled Trial
Published in Microbes, Infection and Chemotherapy (09-12-2022)“…Background. Due to the lack of specific safe medications for the treatment of COVID-19, medications used for other similar conditions are being tested to…”
Get full text
Journal Article -
6
Successful IgM-enriched immunoglobulin treatment in severe COVID-19 pneumonia: a case report
Published in Microbes, Infection and Chemotherapy (24-03-2022)“…Coronavirus disease (COVID-19) pandemic has turned into one of the most considerable challenges worldwide. The optimal treatment strategy, particularly in…”
Get full text
Journal Article -
7
Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial
Published in International immunopharmacology (01-10-2021)“…•Adalimumab was not effective in the management of severe COVID-19 cases.•Adalimumab did not improve symptoms in severe COVID-19 cases.•TNF-α levels should be…”
Get full text
Journal Article -
8
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial
Published in International immunopharmacology (01-08-2020)“…Recently, a new coronavirus spreads rapidly throughout the countries and resulted in a worldwide epidemic. Interferons have direct antiviral and…”
Get full text
Journal Article -
9
Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial
Published in International immunopharmacology (01-10-2021)“…•Ciclosporin may not be helpful in COVID-19 cases not responding to dexamethasone.•Combined ciclosporin and favipiravir therapy, may not be beneficial in…”
Get full text
Journal Article -
10
Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial
Published in International immunopharmacology (01-12-2020)“…[Display omitted] •Excessive inflammation leads to lung damage in complicated COVID-19 patients.•Tocilizumab, an IL-6 inhibitor, was added to the standard…”
Get full text
Journal Article -
11
Extracorporeal membrane oxygenation and COVID‐19: The causes of failure
Published in Journal of cardiac surgery (01-10-2020)“…Introduction Venovenous extracorporeal membrane oxygenation (VV‐ECMO) is a therapeutic strategy for the coronavirus disease 2019 (COVID‐19) induced acute…”
Get full text
Journal Article -
12
Impact of clinical pharmacist‐led antibiotic stewardship program on clinical outcomes in a tertiary referral hospital
Published in Journal of pharmacy practice and research (01-12-2021)“…Aims To evaluate the clinical outcomes of a clinical pharmacist‐led antibiotic stewardship program (ASP). Methods and Results A prospective study of the ASP…”
Get full text
Journal Article -
13
Favipiravir Effects on the Control of Clinical Symptoms of Hospitalized COVID-19 Cases: An Experience with Iranian Formulated Dosage Form
Published in Iranian journal of pharmaceutical research : IJPR (01-01-2021)“…Coronavirus disease -19 (COVID-19) pandemic, caused by SARS-CoV-2, has gradually spread worldwide, becoming a major public health event. This situation…”
Get full text
Journal Article -
14
Extracorporeal membrane oxygenation and COVID-19: The causes of failure
Published in Journal of cardiac surgery (01-10-2020)“…INTRODUCTIONVenovenous extracorporeal membrane oxygenation (VV-ECMO) is a therapeutic strategy for the coronavirus disease 2019 (COVID-19) induced acute…”
Get full text
Report